Clinical Trial Working Groups
|
Goal for 2014: One concept from each institution. To date, 14 concepts have been received from 10 institutions! Concepts in the current BTCRC pipeline are outlined below.
GU:
-
Approved LOI: Renal cell carcinoma (Illinois).
- Concept: Prostate (Indiana).
- Co-chairs: Mark Stein (Rutgers), Ajjai Alva (Michigan).
- Next call: Friday, Sept. 12 at 9:30 a.m. ET / 8:30 a.m. CT.
Thoracic:
-
Concept: Non-small cell lung cancer (Indiana).
- Concept: Non-small cell lung cancer (Michigan).
- Concept: Small cell lung cancer (Nebraska).
- Co-chairs: Arkadiusz Dudek (Illinois), Nasser Hanna (Indiana).
- Next call: Thursday, Oct. 9 at
3 p.m. ET / 2 p.m. CT.
GI:
-
Approved LOI: Hepatocellular (Indiana).
- Concepts in process (not yet presented to CTWG): Esophageal (Iowa), colorectal (Wisconsin).
- Co-chairs: Al B. Benson III (Northwestern), Salma Jabbour (Rutgers).
- Next call: Thursday, Sept. 11 at 10 a.m. ET / 9 a.m. CT.
Breast:
-
Concept: Triple negative metastatic breast cancer (Penn State).
- Concept: Triple negative metastatic breast cancer (Rutgers).
- Concept in process (not yet presented to CTWG): ER+ and/or PR+ and HER2- breast cancer (Illinois).
- Co-chairs: Deborah Toppmeyer (Rutgers), Kari Wisinski (Wisconsin).
- Next call: Wednesday, Sept. 10 at 3 p.m. ET / 2 p.m. CT.
Next working groups to form: GYN and melanoma.
Please contact Jessica Roy, research development director, at [email protected] or 317-634-5842 ext. 19, to join a clinical trial working group or submit a concept.
|